The People's Plant: the community-powered cannabis brand that raised, then raised again

The name says it all. The People's Plant set out to build a medicinal cannabis company with community at its core — "cannabis by the people, for the people" — and it has turned that ethos into one of the more compelling momentum stories on the platform, raising successfully not once but twice, with the second campaign reaching well into seven figures.

A brand built on belonging

Based in the Noosa region of Queensland, The People's Plant has leaned into a sense of local pride and shared ownership from the start. Its messaging is unapologetically community-powered, emphasising sustainable cultivation, responsible consumption and a genuine connection to the place and people around it — even hosting local civic leaders on-site during its campaign to showcase progress and explore how the company and the community could support one another. That grassroots, "we're in this together" positioning isn't just marketing; it's the foundation of how the company raises capital.

Medicinal cannabis has been one of equity crowdfunding's strongest categories in Australia, powered by investors who want to support the growth of a homegrown industry. The People's Plant tapped that enthusiasm — but layered on top of it something distinctive: an explicit invitation for supporters to become part-owners of a brand that defines itself by its community.

The first raise: proof of demand

The company's first Birchal campaign raised around $1 million from more than 600 investors — a strong result that did two things at once. It funded the next stage of the business, and, just as importantly, it proved that broad public interest existed for the company's mission and model. As the company itself noted, the campaign demonstrated confidence in its vision well beyond its immediate circle.

That first raise also generated something every founder hopes for: so much interest that the natural next step was to do it again.

The second raise: momentum compounds

Buoyed by the response to its first campaign, The People's Plant returned to Birchal and ran a second raise that comfortably outperformed the first — bringing in more than $1.3 million from close to 800 investors and getting most of the way to its maximum target. Growing both the dollars raised and the size of the investor community between campaigns is exactly the trajectory founders want to see. It signals that the company didn't just capture a one-time burst of enthusiasm; it built a base that expanded over time.

The second campaign was pitched around expanding operations and meeting growing demand — a concrete, forward-looking use of funds that gave both returning and new investors a clear reason to back the next chapter.

Why the momentum built

The People's Plant's two campaigns illustrate how momentum compounds when a company nurtures it deliberately. The first raise created a community of owner-advocates and a public track record of support. That community, in turn, became the warm audience that powered a stronger second campaign — supplemented by new investors drawn in by the visible enthusiasm. Each campaign made the next one easier, because the company kept its supporters engaged and gave them a reason to stay involved.

There's also a lesson in the brand's consistency. From its name to its messaging to its on-the-ground community engagement, The People's Plant has been relentlessly on-theme. When everything about a company reinforces the idea that backers are part of something they belong to, asking those backers to invest feels less like a pitch and more like an invitation. That alignment between brand and raise is a quiet superpower.

What founders can learn

The first takeaway is that authenticity of community matters. Plenty of companies say they value their community; The People's Plant built its entire identity around it, and that made its crowd raises feel like a natural extension of the brand rather than a bolt-on. The second is that a successful first raise is the best possible preparation for a bigger second one — provided you keep the relationship warm. The third is that growing both your raise size and your investor count over successive campaigns is the clearest sign you're building durable support, not just catching a moment.

For founders wondering whether to view crowdfunding as a single event or an ongoing strategy, The People's Plant offers a clear answer: treat your first campaign as the beginning of a community, keep that community close, and momentum can carry you further than you expected.

Sustainability and place at the core

Part of what makes The People's Plant's community model ring true is how tightly it's woven to sustainability and to a sense of place. The company has leaned into responsible, sustainable cultivation as a defining feature rather than a footnote, and it has engaged its local Noosa community directly — hosting civic leaders on-site and framing its growth as something the region grows alongside. For investors, that local rootedness offers reassurance that the brand's community ethos is genuine, not a marketing veneer applied for campaign season.

It also gives the company a wider story to tell. Medicinal cannabis sits at an intersection of healthcare, agriculture and shifting public attitudes, and a brand that pairs that opportunity with a credible sustainability stance and a community-first identity can appeal to investors on several fronts at once — those drawn to the category's growth, those who care about how products are made, and those who simply want to back a brand that feels like it belongs to them. The second raise, pitched around expanding operations to meet growing demand, channelled all of that into a concrete next step. The result — a larger raise and a bigger investor community than the first time around — suggests the company's blend of purpose, place and product is resonating well beyond its original supporters.

You can explore The People's Plant profile and campaign history on Birchal.

This article is general information only and is not financial advice or an offer of securities. Past campaign performance is not indicative of future results. Investing in early-stage companies involves significant risk, including the loss of your investment. Always read the relevant CSF offer document and the general CSF risk warning before investing.